165 related articles for article (PubMed ID: 20043395)
21. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
22. Intensive lipid-lowering therapy: obvious benefits, possible risks.
Zimlichman E; Szyper-Kravitz M; Katz U; Shoenfeld Y
Isr Med Assoc J; 2006 Dec; 8(12):890-1. PubMed ID: 17214117
[No Abstract] [Full Text] [Related]
23. [Substantiation of increasing doses of statins in clinical practice].
Susekov AV
Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
[No Abstract] [Full Text] [Related]
24. Combination therapy with statins and omega-3 fatty acids.
Nambi V; Ballantyne CM
Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
[TBL] [Abstract][Full Text] [Related]
25. When a statin fails.
Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
[No Abstract] [Full Text] [Related]
26. [Prevention of coronary heart disease with statins. Which patients profit?].
Adam O; Forth W
MMW Fortschr Med; 2003 Jun; 145(25):37-40. PubMed ID: 12891851
[TBL] [Abstract][Full Text] [Related]
27. Update on statins.
Mason P
J Vasc Nurs; 2004 Jun; 22(2):49-50. PubMed ID: 15179417
[No Abstract] [Full Text] [Related]
28. Management of hyperlipidemia in the elderly population: an evidence-based approach.
Dalal D; Robbins JA
South Med J; 2002 Nov; 95(11):1255-61. PubMed ID: 12539990
[TBL] [Abstract][Full Text] [Related]
29. Which dose of omega-3 fatty acids must be taken in different cases of hypertriglyceridemia?
Mogoş T; Dondoi C
Rom J Intern Med; 2008; 46(1):81-6. PubMed ID: 19157275
[TBL] [Abstract][Full Text] [Related]
30. [Lipid therapy is effective in concomitant risk. In this way statins can be prescribed in a budget-appropriate manner].
MMW Fortschr Med; 2000 Mar; 142(13):48-9. PubMed ID: 10783625
[No Abstract] [Full Text] [Related]
31. Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
Benes LB; Bassi NS; Davidson MH
Vasc Health Risk Manag; 2016; 12():481-490. PubMed ID: 28003756
[TBL] [Abstract][Full Text] [Related]
32. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome?
Turhan H; Yetkin E
Int J Cardiol; 2006 Jun; 110(2):276-7. PubMed ID: 16364471
[TBL] [Abstract][Full Text] [Related]
33. Rosuvastatin--a new lipid-lowering drug.
Med Lett Drugs Ther; 2003 Oct; 45(1167):81-3. PubMed ID: 14534507
[No Abstract] [Full Text] [Related]
34. Hypertriglyceridemia.
Oh R
N Engl J Med; 2008 Jan; 358(3):310; author reply 310-1. PubMed ID: 18199874
[No Abstract] [Full Text] [Related]
35. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
36. Managing dyslipidemia in chronic kidney disease.
Harper CR; Jacobson TA
J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
[TBL] [Abstract][Full Text] [Related]
37. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease].
Syvänne M
Duodecim; 1998; 114(15):1503-8. PubMed ID: 11552239
[No Abstract] [Full Text] [Related]
39. [Which indications for statins besides their cholesterol-lowering effect?].
Scheen AJ; Sadzot B
Rev Med Suisse; 2005 Aug; 1(30):1954, 1956-9. PubMed ID: 16200939
[TBL] [Abstract][Full Text] [Related]
40. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials.
Briel M; Studer M; Glass TR; Bucher HC
Am J Med; 2004 Oct; 117(8):596-606. PubMed ID: 15465509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
